RecruitingNot ApplicableNCT05601037

LymphoVenous Anastomosis to Prevent Breast Cancer Related Lymphedema

Lymfo-Veneuse Anastomosen Ter Preventie Van Lymphoedeem

Sponsor

University Hospital, Ghent

Enrollment

80 participants

Start Date

Jun 30, 2021

Study Type

INTERVENTIONAL

Conditions

Lymphedema, Breast Cancer

Summary

Lymphedema is defined as a chronic condition, caused by lymphostasis. A major part in the Western world consists of iatrogenic lymphedema caused by surgery to the lymph nodes of the axilla or groin. Prophylactic lymphovenous anastomosis (LVA) could be beneficial in the prevention of lymphedema of the extremities.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This study tests a microsurgery technique called lymphovenous anastomosis (LVA) to prevent lymphedema — the painful arm swelling that can develop after lymph nodes are removed during breast cancer surgery. The procedure connects disrupted lymphatic vessels directly to small veins to help fluid drain properly. **You may be eligible if...** - You have breast cancer that requires removal of lymph nodes (axillary lymph node dissection) - You do not currently have lymphedema **You may NOT be eligible if...** - You already have lymphedema in the affected arm - Your BMI is greater than 35 Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.